Laidlaw & Company Makes Investing In Businesses Easier

There are a lot of people like me who want to invest in businesses, but we have no idea how to do this on our own. We have not been able to put our money where we wanted, and that makes it hard to be confident about our investments. I came to Laidlaw & Company and talked to Matthew Eitner about how I could invest for the future, and he showed me really easy ways to make money from business investment. It became very simple for me to invest when I got assigned to James Ahern, and then I made sure that I was ready to make more investments once I was comfortable.

My broker at Laidlaw & Company has been helping me understand all the different places that I can invest, and she has been showing me that there is a lot of potential for my investments. I have been able to make more money on my investments pretty easily because I keep investing in things that make the most sense to me. I can support my investments with the justification that I have been using for every new kind of investment, and I can talk it over with my broker when I want to.

It feels really nice to get the investments that I need done, and I know that I am supporting businesses that can really use my help. I have been able to make changes to my portfolio as many times as I want, and I have also been able to change the way that I am approaching my investments. I could be part owner of a business in the future, and I can thank Laidlaw & Company for helping me find these places to invest. They made it very easy for me as a new investor.

Original Source:

http://www.securitiesarbitration.com/news/2004/12/02/ex-sands-bros-clients-fear-firm-will-shirk-awards/

RELMADA’S LAWSUIT AGAINST LAIDLAW.

Relmada Therapeutics a pharmaceutical company has recently filed a motion to amend its complaint against Laidlaw, its investment banker. The amended lawsuit contains a lawful claim grounded on Laidlaw’s breach of the fiduciary duty it owed Relmada. Relmada also seeks to be paid damages following the treachery actions of Laidlaw.
This move by Relmada is to ensure their investment banker does not hurt them in future. Laidlaw has a history of similar actions. The company feels that by so doing they protect the interests of their stockholders. The move by Laidlaw to expose Relmada impacted negatively on the company’s stock price. The current stock price is at $1.65 down from its previous $4.03 price per share.

Laidlaw & company (UK) Ltd is an investment bank broker that provides stock banking and capital management services to individuals and institutions in the USA and the UK. The finance investment accessories offered here engulf capital creation by assignment of equity with influential and high net valued retail stakeholders, acquisition financing, the organization of national exchange schedules, the USA trading markets, listing transactions in the UK, and initial public submissions. They also offer advice on acquisitions, fairness views, and economic restructuring.

Laidlaw has in the past carried out fraudulent activities. For example, in 2013 Leonard Gallick, by then an employee of this investment bank oversaw unsuitable trade and faced criminal charges. Laidlaw’s principals, Matthew Eitner, and James Ahern in a quest to control Reldmada disseminated misleading and false information about Reldmada. This lead to the court issuing a restraining order and an injunction against these two principles and Laidlaw.

Original Source:

http://www.prnewswire.com/news-releases/relmada-therapeutics-files-amended-complaint-against-laidlaw-and-its-principals-matthew-eitner-and-james-ahern-300209454.html